113 related articles for article (PubMed ID: 16279778)
1. Antitumor polycyclic acridines. 17. Synthesis and pharmaceutical profiles of pentacyclic acridinium salts designed to destabilize telomeric integrity.
Cookson JC; Heald RA; Stevens MF
J Med Chem; 2005 Nov; 48(23):7198-207. PubMed ID: 16279778
[TBL] [Abstract][Full Text] [Related]
2. Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents.
Cheng MK; Modi C; Cookson JC; Hutchinson I; Heald RA; McCarroll AJ; Missailidis S; Tanious F; Wilson WD; Mergny JL; Laughton CA; Stevens MF
J Med Chem; 2008 Feb; 51(4):963-75. PubMed ID: 18247546
[TBL] [Abstract][Full Text] [Related]
3. Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts.
Heald RA; Modi C; Cookson JC; Hutchinson I; Laughton CA; Gowan SM; Kelland LR; Stevens MF
J Med Chem; 2002 Jan; 45(3):590-7. PubMed ID: 11806711
[TBL] [Abstract][Full Text] [Related]
4. Antitumour polycyclic acridines. Palladium(0) mediated syntheses of quino[4,3,2-kl]acridines bearing peripheral substituents as potential telomere maintenance inhibitors.
Heald RA; Stevens MF
Org Biomol Chem; 2003 Oct; 1(19):3377-89. PubMed ID: 14584801
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and properties of bioactive 2- and 3-amino-8-methyl-8H-quino[4,3,2-kl]acridine and 8,13-dimethyl-8H-quino[4,3,2-kl]acridinium salts.
Hutchinson I; McCarroll AJ; Heald RA; Stevens MF
Org Biomol Chem; 2004 Jan; 2(2):220-8. PubMed ID: 14737646
[TBL] [Abstract][Full Text] [Related]
7. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
[TBL] [Abstract][Full Text] [Related]
8. Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design.
Missailidis S; Stanslas J; Modi C; Ellis MJ; Robins RA; Laughton CA; Stevens MF
Oncol Res; 2002; 13(3):175-89. PubMed ID: 12549627
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.
Laronze-Cochard M; Kim YM; Brassart B; Riou JF; Laronze JY; Sapi J
Eur J Med Chem; 2009 Oct; 44(10):3880-8. PubMed ID: 19467742
[TBL] [Abstract][Full Text] [Related]
10. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
[TBL] [Abstract][Full Text] [Related]
11. Antitumor polycyclic acridines. 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridines.
Stanslas J; Hagan DJ; Ellis MJ; Turner C; Carmichael J; Ward W; Hammonds TR; Stevens MF
J Med Chem; 2000 Apr; 43(8):1563-72. PubMed ID: 10780913
[TBL] [Abstract][Full Text] [Related]
12. RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells.
Lagah S; Tan IL; Radhakrishnan P; Hirst RA; Ward JH; O'Callaghan C; Smith SJ; Stevens MF; Grundy RG; Rahman R
PLoS One; 2014; 9(1):e86187. PubMed ID: 24454961
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs.
Antonini I; Santoni G; Lucciarini R; Amantini C; Sparapani S; Magnano A
J Med Chem; 2006 Nov; 49(24):7198-207. PubMed ID: 17125272
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of modified acridines: the effect of N- and O- substituent in the nitrogenated ring on antitumor activity.
Sánchez I; Reches R; Caignard DH; Renard P; Pujol MD
Eur J Med Chem; 2006 Mar; 41(3):340-52. PubMed ID: 16413635
[TBL] [Abstract][Full Text] [Related]
15. 2,6-Di(omega-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones: novel, potent, cytotoxic, and DNA-binding agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2002 Jan; 45(3):696-702. PubMed ID: 11806721
[TBL] [Abstract][Full Text] [Related]
16. Functionalization of the A ring of pyridoacridine as a route toward greater structural diversity. Synthesis of an octacyclic analogue of eilatin.
Bouffier L; Dinica R; Debray J; Dumy P; Demeunynck M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4836-8. PubMed ID: 19559608
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of 4,5-di-substituted acridone ligands with high G-quadruplex affinity and selectivity, together with low toxicity to normal cells.
Cuenca F; Moore MJ; Johnson K; Guyen B; De Cian A; Neidle S
Bioorg Med Chem Lett; 2009 Sep; 19(17):5109-13. PubMed ID: 19640709
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents.
Martins C; Gunaratnam M; Stuart J; Makwana V; Greciano O; Reszka AP; Kelland LR; Neidle S
Bioorg Med Chem Lett; 2007 Apr; 17(8):2293-8. PubMed ID: 17276687
[TBL] [Abstract][Full Text] [Related]
19. Identification of amino acid appended acridines as potential leads to anti-cancer drugs.
Singh P; Kumar A; Sharma A; Kaur G
Bioorg Med Chem Lett; 2015 Sep; 25(18):3854-8. PubMed ID: 26238321
[TBL] [Abstract][Full Text] [Related]
20. Human telomerase inhibition by substituted acridine derivatives.
Harrison RJ; Gowan SM; Kelland LR; Neidle S
Bioorg Med Chem Lett; 1999 Sep; 9(17):2463-8. PubMed ID: 10498189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
